China SXT Pharmaceuticals (SXTC) Assets Average (2020 - 2025)
Historic Assets Average for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Q3 2025 value amounting to $24.0 million.
- China SXT Pharmaceuticals' Assets Average fell 1128.44% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.0 million, marking a year-over-year decrease of 1128.44%. This contributed to the annual value of $22.4 million for FY2025, which is 1497.79% down from last year.
- Per China SXT Pharmaceuticals' latest filing, its Assets Average stood at $24.0 million for Q3 2025, which was down 1128.44% from $26.3 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Assets Average registered a high of $29.3 million during Q1 2021, and its lowest value of $18.9 million during Q1 2024.
- Its 5-year average for Assets Average is $25.8 million, with a median of $26.7 million in 2024.
- Per our database at Business Quant, China SXT Pharmaceuticals' Assets Average crashed by 2710.02% in 2024 and then skyrocketed by 3962.83% in 2025.
- Quarter analysis of 5 years shows China SXT Pharmaceuticals' Assets Average stood at $28.6 million in 2021, then dropped by 2.6% to $27.9 million in 2022, then dropped by 20.79% to $22.1 million in 2023, then increased by 22.61% to $27.1 million in 2024, then fell by 11.28% to $24.0 million in 2025.
- Its Assets Average was $24.0 million in Q3 2025, compared to $26.3 million in Q1 2025 and $27.1 million in Q3 2024.